Medical Care
Global PEGylation Proteins Technology Market Research Report 2025
- May 05, 25
- ID: 227759
- Pages: 85
- Figures: 86
- Views: 5
The global market for PEGylation Proteins Technology was valued at US$ 2153 million in the year 2024 and is projected to reach a revised size of US$ 4412 million by 2031, growing at a CAGR of 11.0% during the forecast period.
Poly(ethylene glycol) (PEG) is a widely used polymer in drug delivery systems and is often directly conjugated to a drug therapeutic. PEG is a water-soluble, biologically inert, non-immunogenic synthetic polymer consisted of ethylene glycol (-CH2-CH2-O-) in repeating units. PEG is produced by anionic polymerization of ethylene oxide initiated by a nucleophilic attack of a methoxide ion on the epoxide ring. PEGylation of a protein conjugate is the process by which PEG is either non-covalently or covalently attached to a potential protein, peptide or antibody of interest to produce alterations in the physiochemical properties of the macromolecule in areas like conformation, electrostatic binding and hydrophobicity. PEGylation is used as a strategy to overcome challenges such as instability, inadequate circulation half-life and immunogenicity of a drug candidate intended for a therapeutic use.
North American market for PEGylation Proteins Technology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for PEGylation Proteins Technology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for PEGylation Proteins Technology in Pharmaceutical & Biotechnology Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of PEGylation Proteins Technology include Abcam Plc., Aurigene Pharmaceutical Services Ltd., BroadPharm, Creative PEGworks, Celares GmbH, Creative Diagnostics, Enzon Pharmaceuticals, Inc., Laysan Bio, Inc., Merck KGaA, NOF America Corp., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for PEGylation Proteins Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PEGylation Proteins Technology.
The PEGylation Proteins Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global PEGylation Proteins Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PEGylation Proteins Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abcam Plc.
Aurigene Pharmaceutical Services Ltd.
BroadPharm
Creative PEGworks
Celares GmbH
Creative Diagnostics
Enzon Pharmaceuticals, Inc.
Laysan Bio, Inc.
Merck KGaA
NOF America Corp.
Pfizer
Profacgen
Thermo Fisher Scientific, Inc.
Segment by Type
Colony-stimulating Factor
Interferons
Erythropoietin
Recombinant Factor VII
Others
Segment by Application
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Academic & Research Institutes
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of PEGylation Proteins Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Poly(ethylene glycol) (PEG) is a widely used polymer in drug delivery systems and is often directly conjugated to a drug therapeutic. PEG is a water-soluble, biologically inert, non-immunogenic synthetic polymer consisted of ethylene glycol (-CH2-CH2-O-) in repeating units. PEG is produced by anionic polymerization of ethylene oxide initiated by a nucleophilic attack of a methoxide ion on the epoxide ring. PEGylation of a protein conjugate is the process by which PEG is either non-covalently or covalently attached to a potential protein, peptide or antibody of interest to produce alterations in the physiochemical properties of the macromolecule in areas like conformation, electrostatic binding and hydrophobicity. PEGylation is used as a strategy to overcome challenges such as instability, inadequate circulation half-life and immunogenicity of a drug candidate intended for a therapeutic use.
North American market for PEGylation Proteins Technology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for PEGylation Proteins Technology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for PEGylation Proteins Technology in Pharmaceutical & Biotechnology Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of PEGylation Proteins Technology include Abcam Plc., Aurigene Pharmaceutical Services Ltd., BroadPharm, Creative PEGworks, Celares GmbH, Creative Diagnostics, Enzon Pharmaceuticals, Inc., Laysan Bio, Inc., Merck KGaA, NOF America Corp., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for PEGylation Proteins Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PEGylation Proteins Technology.
The PEGylation Proteins Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global PEGylation Proteins Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PEGylation Proteins Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abcam Plc.
Aurigene Pharmaceutical Services Ltd.
BroadPharm
Creative PEGworks
Celares GmbH
Creative Diagnostics
Enzon Pharmaceuticals, Inc.
Laysan Bio, Inc.
Merck KGaA
NOF America Corp.
Pfizer
Profacgen
Thermo Fisher Scientific, Inc.
Segment by Type
Colony-stimulating Factor
Interferons
Erythropoietin
Recombinant Factor VII
Others
Segment by Application
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Academic & Research Institutes
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of PEGylation Proteins Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PEGylation Proteins Technology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Colony-stimulating Factor
1.2.3 Interferons
1.2.4 Erythropoietin
1.2.5 Recombinant Factor VII
1.2.6 Others
1.3 Market by Application
1.3.1 Global PEGylation Proteins Technology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Contract Research Organizations (CROs)
1.3.4 Academic & Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global PEGylation Proteins Technology Market Perspective (2020-2031)
2.2 Global PEGylation Proteins Technology Growth Trends by Region
2.2.1 Global PEGylation Proteins Technology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 PEGylation Proteins Technology Historic Market Size by Region (2020-2025)
2.2.3 PEGylation Proteins Technology Forecasted Market Size by Region (2026-2031)
2.3 PEGylation Proteins Technology Market Dynamics
2.3.1 PEGylation Proteins Technology Industry Trends
2.3.2 PEGylation Proteins Technology Market Drivers
2.3.3 PEGylation Proteins Technology Market Challenges
2.3.4 PEGylation Proteins Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PEGylation Proteins Technology Players by Revenue
3.1.1 Global Top PEGylation Proteins Technology Players by Revenue (2020-2025)
3.1.2 Global PEGylation Proteins Technology Revenue Market Share by Players (2020-2025)
3.2 Global PEGylation Proteins Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by PEGylation Proteins Technology Revenue
3.4 Global PEGylation Proteins Technology Market Concentration Ratio
3.4.1 Global PEGylation Proteins Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PEGylation Proteins Technology Revenue in 2024
3.5 Global Key Players of PEGylation Proteins Technology Head office and Area Served
3.6 Global Key Players of PEGylation Proteins Technology, Product and Application
3.7 Global Key Players of PEGylation Proteins Technology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 PEGylation Proteins Technology Breakdown Data by Type
4.1 Global PEGylation Proteins Technology Historic Market Size by Type (2020-2025)
4.2 Global PEGylation Proteins Technology Forecasted Market Size by Type (2026-2031)
5 PEGylation Proteins Technology Breakdown Data by Application
5.1 Global PEGylation Proteins Technology Historic Market Size by Application (2020-2025)
5.2 Global PEGylation Proteins Technology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America PEGylation Proteins Technology Market Size (2020-2031)
6.2 North America PEGylation Proteins Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America PEGylation Proteins Technology Market Size by Country (2020-2025)
6.4 North America PEGylation Proteins Technology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe PEGylation Proteins Technology Market Size (2020-2031)
7.2 Europe PEGylation Proteins Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe PEGylation Proteins Technology Market Size by Country (2020-2025)
7.4 Europe PEGylation Proteins Technology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PEGylation Proteins Technology Market Size (2020-2031)
8.2 Asia-Pacific PEGylation Proteins Technology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific PEGylation Proteins Technology Market Size by Region (2020-2025)
8.4 Asia-Pacific PEGylation Proteins Technology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America PEGylation Proteins Technology Market Size (2020-2031)
9.2 Latin America PEGylation Proteins Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America PEGylation Proteins Technology Market Size by Country (2020-2025)
9.4 Latin America PEGylation Proteins Technology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PEGylation Proteins Technology Market Size (2020-2031)
10.2 Middle East & Africa PEGylation Proteins Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa PEGylation Proteins Technology Market Size by Country (2020-2025)
10.4 Middle East & Africa PEGylation Proteins Technology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abcam Plc.
11.1.1 Abcam Plc. Company Details
11.1.2 Abcam Plc. Business Overview
11.1.3 Abcam Plc. PEGylation Proteins Technology Introduction
11.1.4 Abcam Plc. Revenue in PEGylation Proteins Technology Business (2020-2025)
11.1.5 Abcam Plc. Recent Development
11.2 Aurigene Pharmaceutical Services Ltd.
11.2.1 Aurigene Pharmaceutical Services Ltd. Company Details
11.2.2 Aurigene Pharmaceutical Services Ltd. Business Overview
11.2.3 Aurigene Pharmaceutical Services Ltd. PEGylation Proteins Technology Introduction
11.2.4 Aurigene Pharmaceutical Services Ltd. Revenue in PEGylation Proteins Technology Business (2020-2025)
11.2.5 Aurigene Pharmaceutical Services Ltd. Recent Development
11.3 BroadPharm
11.3.1 BroadPharm Company Details
11.3.2 BroadPharm Business Overview
11.3.3 BroadPharm PEGylation Proteins Technology Introduction
11.3.4 BroadPharm Revenue in PEGylation Proteins Technology Business (2020-2025)
11.3.5 BroadPharm Recent Development
11.4 Creative PEGworks
11.4.1 Creative PEGworks Company Details
11.4.2 Creative PEGworks Business Overview
11.4.3 Creative PEGworks PEGylation Proteins Technology Introduction
11.4.4 Creative PEGworks Revenue in PEGylation Proteins Technology Business (2020-2025)
11.4.5 Creative PEGworks Recent Development
11.5 Celares GmbH
11.5.1 Celares GmbH Company Details
11.5.2 Celares GmbH Business Overview
11.5.3 Celares GmbH PEGylation Proteins Technology Introduction
11.5.4 Celares GmbH Revenue in PEGylation Proteins Technology Business (2020-2025)
11.5.5 Celares GmbH Recent Development
11.6 Creative Diagnostics
11.6.1 Creative Diagnostics Company Details
11.6.2 Creative Diagnostics Business Overview
11.6.3 Creative Diagnostics PEGylation Proteins Technology Introduction
11.6.4 Creative Diagnostics Revenue in PEGylation Proteins Technology Business (2020-2025)
11.6.5 Creative Diagnostics Recent Development
11.7 Enzon Pharmaceuticals, Inc.
11.7.1 Enzon Pharmaceuticals, Inc. Company Details
11.7.2 Enzon Pharmaceuticals, Inc. Business Overview
11.7.3 Enzon Pharmaceuticals, Inc. PEGylation Proteins Technology Introduction
11.7.4 Enzon Pharmaceuticals, Inc. Revenue in PEGylation Proteins Technology Business (2020-2025)
11.7.5 Enzon Pharmaceuticals, Inc. Recent Development
11.8 Laysan Bio, Inc.
11.8.1 Laysan Bio, Inc. Company Details
11.8.2 Laysan Bio, Inc. Business Overview
11.8.3 Laysan Bio, Inc. PEGylation Proteins Technology Introduction
11.8.4 Laysan Bio, Inc. Revenue in PEGylation Proteins Technology Business (2020-2025)
11.8.5 Laysan Bio, Inc. Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Details
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA PEGylation Proteins Technology Introduction
11.9.4 Merck KGaA Revenue in PEGylation Proteins Technology Business (2020-2025)
11.9.5 Merck KGaA Recent Development
11.10 NOF America Corp.
11.10.1 NOF America Corp. Company Details
11.10.2 NOF America Corp. Business Overview
11.10.3 NOF America Corp. PEGylation Proteins Technology Introduction
11.10.4 NOF America Corp. Revenue in PEGylation Proteins Technology Business (2020-2025)
11.10.5 NOF America Corp. Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Details
11.11.2 Pfizer Business Overview
11.11.3 Pfizer PEGylation Proteins Technology Introduction
11.11.4 Pfizer Revenue in PEGylation Proteins Technology Business (2020-2025)
11.11.5 Pfizer Recent Development
11.12 Profacgen
11.12.1 Profacgen Company Details
11.12.2 Profacgen Business Overview
11.12.3 Profacgen PEGylation Proteins Technology Introduction
11.12.4 Profacgen Revenue in PEGylation Proteins Technology Business (2020-2025)
11.12.5 Profacgen Recent Development
11.13 Thermo Fisher Scientific, Inc.
11.13.1 Thermo Fisher Scientific, Inc. Company Details
11.13.2 Thermo Fisher Scientific, Inc. Business Overview
11.13.3 Thermo Fisher Scientific, Inc. PEGylation Proteins Technology Introduction
11.13.4 Thermo Fisher Scientific, Inc. Revenue in PEGylation Proteins Technology Business (2020-2025)
11.13.5 Thermo Fisher Scientific, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PEGylation Proteins Technology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Colony-stimulating Factor
1.2.3 Interferons
1.2.4 Erythropoietin
1.2.5 Recombinant Factor VII
1.2.6 Others
1.3 Market by Application
1.3.1 Global PEGylation Proteins Technology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Contract Research Organizations (CROs)
1.3.4 Academic & Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global PEGylation Proteins Technology Market Perspective (2020-2031)
2.2 Global PEGylation Proteins Technology Growth Trends by Region
2.2.1 Global PEGylation Proteins Technology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 PEGylation Proteins Technology Historic Market Size by Region (2020-2025)
2.2.3 PEGylation Proteins Technology Forecasted Market Size by Region (2026-2031)
2.3 PEGylation Proteins Technology Market Dynamics
2.3.1 PEGylation Proteins Technology Industry Trends
2.3.2 PEGylation Proteins Technology Market Drivers
2.3.3 PEGylation Proteins Technology Market Challenges
2.3.4 PEGylation Proteins Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PEGylation Proteins Technology Players by Revenue
3.1.1 Global Top PEGylation Proteins Technology Players by Revenue (2020-2025)
3.1.2 Global PEGylation Proteins Technology Revenue Market Share by Players (2020-2025)
3.2 Global PEGylation Proteins Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by PEGylation Proteins Technology Revenue
3.4 Global PEGylation Proteins Technology Market Concentration Ratio
3.4.1 Global PEGylation Proteins Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PEGylation Proteins Technology Revenue in 2024
3.5 Global Key Players of PEGylation Proteins Technology Head office and Area Served
3.6 Global Key Players of PEGylation Proteins Technology, Product and Application
3.7 Global Key Players of PEGylation Proteins Technology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 PEGylation Proteins Technology Breakdown Data by Type
4.1 Global PEGylation Proteins Technology Historic Market Size by Type (2020-2025)
4.2 Global PEGylation Proteins Technology Forecasted Market Size by Type (2026-2031)
5 PEGylation Proteins Technology Breakdown Data by Application
5.1 Global PEGylation Proteins Technology Historic Market Size by Application (2020-2025)
5.2 Global PEGylation Proteins Technology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America PEGylation Proteins Technology Market Size (2020-2031)
6.2 North America PEGylation Proteins Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America PEGylation Proteins Technology Market Size by Country (2020-2025)
6.4 North America PEGylation Proteins Technology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe PEGylation Proteins Technology Market Size (2020-2031)
7.2 Europe PEGylation Proteins Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe PEGylation Proteins Technology Market Size by Country (2020-2025)
7.4 Europe PEGylation Proteins Technology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PEGylation Proteins Technology Market Size (2020-2031)
8.2 Asia-Pacific PEGylation Proteins Technology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific PEGylation Proteins Technology Market Size by Region (2020-2025)
8.4 Asia-Pacific PEGylation Proteins Technology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America PEGylation Proteins Technology Market Size (2020-2031)
9.2 Latin America PEGylation Proteins Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America PEGylation Proteins Technology Market Size by Country (2020-2025)
9.4 Latin America PEGylation Proteins Technology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PEGylation Proteins Technology Market Size (2020-2031)
10.2 Middle East & Africa PEGylation Proteins Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa PEGylation Proteins Technology Market Size by Country (2020-2025)
10.4 Middle East & Africa PEGylation Proteins Technology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abcam Plc.
11.1.1 Abcam Plc. Company Details
11.1.2 Abcam Plc. Business Overview
11.1.3 Abcam Plc. PEGylation Proteins Technology Introduction
11.1.4 Abcam Plc. Revenue in PEGylation Proteins Technology Business (2020-2025)
11.1.5 Abcam Plc. Recent Development
11.2 Aurigene Pharmaceutical Services Ltd.
11.2.1 Aurigene Pharmaceutical Services Ltd. Company Details
11.2.2 Aurigene Pharmaceutical Services Ltd. Business Overview
11.2.3 Aurigene Pharmaceutical Services Ltd. PEGylation Proteins Technology Introduction
11.2.4 Aurigene Pharmaceutical Services Ltd. Revenue in PEGylation Proteins Technology Business (2020-2025)
11.2.5 Aurigene Pharmaceutical Services Ltd. Recent Development
11.3 BroadPharm
11.3.1 BroadPharm Company Details
11.3.2 BroadPharm Business Overview
11.3.3 BroadPharm PEGylation Proteins Technology Introduction
11.3.4 BroadPharm Revenue in PEGylation Proteins Technology Business (2020-2025)
11.3.5 BroadPharm Recent Development
11.4 Creative PEGworks
11.4.1 Creative PEGworks Company Details
11.4.2 Creative PEGworks Business Overview
11.4.3 Creative PEGworks PEGylation Proteins Technology Introduction
11.4.4 Creative PEGworks Revenue in PEGylation Proteins Technology Business (2020-2025)
11.4.5 Creative PEGworks Recent Development
11.5 Celares GmbH
11.5.1 Celares GmbH Company Details
11.5.2 Celares GmbH Business Overview
11.5.3 Celares GmbH PEGylation Proteins Technology Introduction
11.5.4 Celares GmbH Revenue in PEGylation Proteins Technology Business (2020-2025)
11.5.5 Celares GmbH Recent Development
11.6 Creative Diagnostics
11.6.1 Creative Diagnostics Company Details
11.6.2 Creative Diagnostics Business Overview
11.6.3 Creative Diagnostics PEGylation Proteins Technology Introduction
11.6.4 Creative Diagnostics Revenue in PEGylation Proteins Technology Business (2020-2025)
11.6.5 Creative Diagnostics Recent Development
11.7 Enzon Pharmaceuticals, Inc.
11.7.1 Enzon Pharmaceuticals, Inc. Company Details
11.7.2 Enzon Pharmaceuticals, Inc. Business Overview
11.7.3 Enzon Pharmaceuticals, Inc. PEGylation Proteins Technology Introduction
11.7.4 Enzon Pharmaceuticals, Inc. Revenue in PEGylation Proteins Technology Business (2020-2025)
11.7.5 Enzon Pharmaceuticals, Inc. Recent Development
11.8 Laysan Bio, Inc.
11.8.1 Laysan Bio, Inc. Company Details
11.8.2 Laysan Bio, Inc. Business Overview
11.8.3 Laysan Bio, Inc. PEGylation Proteins Technology Introduction
11.8.4 Laysan Bio, Inc. Revenue in PEGylation Proteins Technology Business (2020-2025)
11.8.5 Laysan Bio, Inc. Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Details
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA PEGylation Proteins Technology Introduction
11.9.4 Merck KGaA Revenue in PEGylation Proteins Technology Business (2020-2025)
11.9.5 Merck KGaA Recent Development
11.10 NOF America Corp.
11.10.1 NOF America Corp. Company Details
11.10.2 NOF America Corp. Business Overview
11.10.3 NOF America Corp. PEGylation Proteins Technology Introduction
11.10.4 NOF America Corp. Revenue in PEGylation Proteins Technology Business (2020-2025)
11.10.5 NOF America Corp. Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Details
11.11.2 Pfizer Business Overview
11.11.3 Pfizer PEGylation Proteins Technology Introduction
11.11.4 Pfizer Revenue in PEGylation Proteins Technology Business (2020-2025)
11.11.5 Pfizer Recent Development
11.12 Profacgen
11.12.1 Profacgen Company Details
11.12.2 Profacgen Business Overview
11.12.3 Profacgen PEGylation Proteins Technology Introduction
11.12.4 Profacgen Revenue in PEGylation Proteins Technology Business (2020-2025)
11.12.5 Profacgen Recent Development
11.13 Thermo Fisher Scientific, Inc.
11.13.1 Thermo Fisher Scientific, Inc. Company Details
11.13.2 Thermo Fisher Scientific, Inc. Business Overview
11.13.3 Thermo Fisher Scientific, Inc. PEGylation Proteins Technology Introduction
11.13.4 Thermo Fisher Scientific, Inc. Revenue in PEGylation Proteins Technology Business (2020-2025)
11.13.5 Thermo Fisher Scientific, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global PEGylation Proteins Technology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Colony-stimulating Factor
Table 3. Key Players of Interferons
Table 4. Key Players of Erythropoietin
Table 5. Key Players of Recombinant Factor VII
Table 6. Key Players of Others
Table 7. Global PEGylation Proteins Technology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global PEGylation Proteins Technology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global PEGylation Proteins Technology Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global PEGylation Proteins Technology Market Share by Region (2020-2025)
Table 11. Global PEGylation Proteins Technology Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global PEGylation Proteins Technology Market Share by Region (2026-2031)
Table 13. PEGylation Proteins Technology Market Trends
Table 14. PEGylation Proteins Technology Market Drivers
Table 15. PEGylation Proteins Technology Market Challenges
Table 16. PEGylation Proteins Technology Market Restraints
Table 17. Global PEGylation Proteins Technology Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global PEGylation Proteins Technology Market Share by Players (2020-2025)
Table 19. Global Top PEGylation Proteins Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PEGylation Proteins Technology as of 2024)
Table 20. Ranking of Global Top PEGylation Proteins Technology Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by PEGylation Proteins Technology Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of PEGylation Proteins Technology, Headquarters and Area Served
Table 23. Global Key Players of PEGylation Proteins Technology, Product and Application
Table 24. Global Key Players of PEGylation Proteins Technology, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global PEGylation Proteins Technology Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global PEGylation Proteins Technology Revenue Market Share by Type (2020-2025)
Table 28. Global PEGylation Proteins Technology Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global PEGylation Proteins Technology Revenue Market Share by Type (2026-2031)
Table 30. Global PEGylation Proteins Technology Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global PEGylation Proteins Technology Revenue Market Share by Application (2020-2025)
Table 32. Global PEGylation Proteins Technology Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global PEGylation Proteins Technology Revenue Market Share by Application (2026-2031)
Table 34. North America PEGylation Proteins Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America PEGylation Proteins Technology Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America PEGylation Proteins Technology Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe PEGylation Proteins Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe PEGylation Proteins Technology Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe PEGylation Proteins Technology Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific PEGylation Proteins Technology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific PEGylation Proteins Technology Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific PEGylation Proteins Technology Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America PEGylation Proteins Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America PEGylation Proteins Technology Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America PEGylation Proteins Technology Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa PEGylation Proteins Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa PEGylation Proteins Technology Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa PEGylation Proteins Technology Market Size by Country (2026-2031) & (US$ Million)
Table 49. Abcam Plc. Company Details
Table 50. Abcam Plc. Business Overview
Table 51. Abcam Plc. PEGylation Proteins Technology Product
Table 52. Abcam Plc. Revenue in PEGylation Proteins Technology Business (2020-2025) & (US$ Million)
Table 53. Abcam Plc. Recent Development
Table 54. Aurigene Pharmaceutical Services Ltd. Company Details
Table 55. Aurigene Pharmaceutical Services Ltd. Business Overview
Table 56. Aurigene Pharmaceutical Services Ltd. PEGylation Proteins Technology Product
Table 57. Aurigene Pharmaceutical Services Ltd. Revenue in PEGylation Proteins Technology Business (2020-2025) & (US$ Million)
Table 58. Aurigene Pharmaceutical Services Ltd. Recent Development
Table 59. BroadPharm Company Details
Table 60. BroadPharm Business Overview
Table 61. BroadPharm PEGylation Proteins Technology Product
Table 62. BroadPharm Revenue in PEGylation Proteins Technology Business (2020-2025) & (US$ Million)
Table 63. BroadPharm Recent Development
Table 64. Creative PEGworks Company Details
Table 65. Creative PEGworks Business Overview
Table 66. Creative PEGworks PEGylation Proteins Technology Product
Table 67. Creative PEGworks Revenue in PEGylation Proteins Technology Business (2020-2025) & (US$ Million)
Table 68. Creative PEGworks Recent Development
Table 69. Celares GmbH Company Details
Table 70. Celares GmbH Business Overview
Table 71. Celares GmbH PEGylation Proteins Technology Product
Table 72. Celares GmbH Revenue in PEGylation Proteins Technology Business (2020-2025) & (US$ Million)
Table 73. Celares GmbH Recent Development
Table 74. Creative Diagnostics Company Details
Table 75. Creative Diagnostics Business Overview
Table 76. Creative Diagnostics PEGylation Proteins Technology Product
Table 77. Creative Diagnostics Revenue in PEGylation Proteins Technology Business (2020-2025) & (US$ Million)
Table 78. Creative Diagnostics Recent Development
Table 79. Enzon Pharmaceuticals, Inc. Company Details
Table 80. Enzon Pharmaceuticals, Inc. Business Overview
Table 81. Enzon Pharmaceuticals, Inc. PEGylation Proteins Technology Product
Table 82. Enzon Pharmaceuticals, Inc. Revenue in PEGylation Proteins Technology Business (2020-2025) & (US$ Million)
Table 83. Enzon Pharmaceuticals, Inc. Recent Development
Table 84. Laysan Bio, Inc. Company Details
Table 85. Laysan Bio, Inc. Business Overview
Table 86. Laysan Bio, Inc. PEGylation Proteins Technology Product
Table 87. Laysan Bio, Inc. Revenue in PEGylation Proteins Technology Business (2020-2025) & (US$ Million)
Table 88. Laysan Bio, Inc. Recent Development
Table 89. Merck KGaA Company Details
Table 90. Merck KGaA Business Overview
Table 91. Merck KGaA PEGylation Proteins Technology Product
Table 92. Merck KGaA Revenue in PEGylation Proteins Technology Business (2020-2025) & (US$ Million)
Table 93. Merck KGaA Recent Development
Table 94. NOF America Corp. Company Details
Table 95. NOF America Corp. Business Overview
Table 96. NOF America Corp. PEGylation Proteins Technology Product
Table 97. NOF America Corp. Revenue in PEGylation Proteins Technology Business (2020-2025) & (US$ Million)
Table 98. NOF America Corp. Recent Development
Table 99. Pfizer Company Details
Table 100. Pfizer Business Overview
Table 101. Pfizer PEGylation Proteins Technology Product
Table 102. Pfizer Revenue in PEGylation Proteins Technology Business (2020-2025) & (US$ Million)
Table 103. Pfizer Recent Development
Table 104. Profacgen Company Details
Table 105. Profacgen Business Overview
Table 106. Profacgen PEGylation Proteins Technology Product
Table 107. Profacgen Revenue in PEGylation Proteins Technology Business (2020-2025) & (US$ Million)
Table 108. Profacgen Recent Development
Table 109. Thermo Fisher Scientific, Inc. Company Details
Table 110. Thermo Fisher Scientific, Inc. Business Overview
Table 111. Thermo Fisher Scientific, Inc. PEGylation Proteins Technology Product
Table 112. Thermo Fisher Scientific, Inc. Revenue in PEGylation Proteins Technology Business (2020-2025) & (US$ Million)
Table 113. Thermo Fisher Scientific, Inc. Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
Table 117. Authors List of This Report
List of Figures
Figure 1. PEGylation Proteins Technology Picture
Figure 2. Global PEGylation Proteins Technology Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global PEGylation Proteins Technology Market Share by Type: 2024 VS 2031
Figure 4. Colony-stimulating Factor Features
Figure 5. Interferons Features
Figure 6. Erythropoietin Features
Figure 7. Recombinant Factor VII Features
Figure 8. Others Features
Figure 9. Global PEGylation Proteins Technology Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global PEGylation Proteins Technology Market Share by Application: 2024 VS 2031
Figure 11. Pharmaceutical & Biotechnology Companies Case Studies
Figure 12. Contract Research Organizations (CROs) Case Studies
Figure 13. Academic & Research Institutes Case Studies
Figure 14. PEGylation Proteins Technology Report Years Considered
Figure 15. Global PEGylation Proteins Technology Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global PEGylation Proteins Technology Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global PEGylation Proteins Technology Market Share by Region: 2024 VS 2031
Figure 18. Global PEGylation Proteins Technology Market Share by Players in 2024
Figure 19. Global Top PEGylation Proteins Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PEGylation Proteins Technology as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by PEGylation Proteins Technology Revenue in 2024
Figure 21. North America PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America PEGylation Proteins Technology Market Share by Country (2020-2031)
Figure 23. United States PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe PEGylation Proteins Technology Market Share by Country (2020-2031)
Figure 27. Germany PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific PEGylation Proteins Technology Market Share by Region (2020-2031)
Figure 35. China PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America PEGylation Proteins Technology Market Share by Country (2020-2031)
Figure 43. Mexico PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa PEGylation Proteins Technology Market Share by Country (2020-2031)
Figure 47. Turkey PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Abcam Plc. Revenue Growth Rate in PEGylation Proteins Technology Business (2020-2025)
Figure 51. Aurigene Pharmaceutical Services Ltd. Revenue Growth Rate in PEGylation Proteins Technology Business (2020-2025)
Figure 52. BroadPharm Revenue Growth Rate in PEGylation Proteins Technology Business (2020-2025)
Figure 53. Creative PEGworks Revenue Growth Rate in PEGylation Proteins Technology Business (2020-2025)
Figure 54. Celares GmbH Revenue Growth Rate in PEGylation Proteins Technology Business (2020-2025)
Figure 55. Creative Diagnostics Revenue Growth Rate in PEGylation Proteins Technology Business (2020-2025)
Figure 56. Enzon Pharmaceuticals, Inc. Revenue Growth Rate in PEGylation Proteins Technology Business (2020-2025)
Figure 57. Laysan Bio, Inc. Revenue Growth Rate in PEGylation Proteins Technology Business (2020-2025)
Figure 58. Merck KGaA Revenue Growth Rate in PEGylation Proteins Technology Business (2020-2025)
Figure 59. NOF America Corp. Revenue Growth Rate in PEGylation Proteins Technology Business (2020-2025)
Figure 60. Pfizer Revenue Growth Rate in PEGylation Proteins Technology Business (2020-2025)
Figure 61. Profacgen Revenue Growth Rate in PEGylation Proteins Technology Business (2020-2025)
Figure 62. Thermo Fisher Scientific, Inc. Revenue Growth Rate in PEGylation Proteins Technology Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global PEGylation Proteins Technology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Colony-stimulating Factor
Table 3. Key Players of Interferons
Table 4. Key Players of Erythropoietin
Table 5. Key Players of Recombinant Factor VII
Table 6. Key Players of Others
Table 7. Global PEGylation Proteins Technology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global PEGylation Proteins Technology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global PEGylation Proteins Technology Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global PEGylation Proteins Technology Market Share by Region (2020-2025)
Table 11. Global PEGylation Proteins Technology Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global PEGylation Proteins Technology Market Share by Region (2026-2031)
Table 13. PEGylation Proteins Technology Market Trends
Table 14. PEGylation Proteins Technology Market Drivers
Table 15. PEGylation Proteins Technology Market Challenges
Table 16. PEGylation Proteins Technology Market Restraints
Table 17. Global PEGylation Proteins Technology Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global PEGylation Proteins Technology Market Share by Players (2020-2025)
Table 19. Global Top PEGylation Proteins Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PEGylation Proteins Technology as of 2024)
Table 20. Ranking of Global Top PEGylation Proteins Technology Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by PEGylation Proteins Technology Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of PEGylation Proteins Technology, Headquarters and Area Served
Table 23. Global Key Players of PEGylation Proteins Technology, Product and Application
Table 24. Global Key Players of PEGylation Proteins Technology, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global PEGylation Proteins Technology Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global PEGylation Proteins Technology Revenue Market Share by Type (2020-2025)
Table 28. Global PEGylation Proteins Technology Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global PEGylation Proteins Technology Revenue Market Share by Type (2026-2031)
Table 30. Global PEGylation Proteins Technology Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global PEGylation Proteins Technology Revenue Market Share by Application (2020-2025)
Table 32. Global PEGylation Proteins Technology Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global PEGylation Proteins Technology Revenue Market Share by Application (2026-2031)
Table 34. North America PEGylation Proteins Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America PEGylation Proteins Technology Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America PEGylation Proteins Technology Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe PEGylation Proteins Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe PEGylation Proteins Technology Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe PEGylation Proteins Technology Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific PEGylation Proteins Technology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific PEGylation Proteins Technology Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific PEGylation Proteins Technology Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America PEGylation Proteins Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America PEGylation Proteins Technology Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America PEGylation Proteins Technology Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa PEGylation Proteins Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa PEGylation Proteins Technology Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa PEGylation Proteins Technology Market Size by Country (2026-2031) & (US$ Million)
Table 49. Abcam Plc. Company Details
Table 50. Abcam Plc. Business Overview
Table 51. Abcam Plc. PEGylation Proteins Technology Product
Table 52. Abcam Plc. Revenue in PEGylation Proteins Technology Business (2020-2025) & (US$ Million)
Table 53. Abcam Plc. Recent Development
Table 54. Aurigene Pharmaceutical Services Ltd. Company Details
Table 55. Aurigene Pharmaceutical Services Ltd. Business Overview
Table 56. Aurigene Pharmaceutical Services Ltd. PEGylation Proteins Technology Product
Table 57. Aurigene Pharmaceutical Services Ltd. Revenue in PEGylation Proteins Technology Business (2020-2025) & (US$ Million)
Table 58. Aurigene Pharmaceutical Services Ltd. Recent Development
Table 59. BroadPharm Company Details
Table 60. BroadPharm Business Overview
Table 61. BroadPharm PEGylation Proteins Technology Product
Table 62. BroadPharm Revenue in PEGylation Proteins Technology Business (2020-2025) & (US$ Million)
Table 63. BroadPharm Recent Development
Table 64. Creative PEGworks Company Details
Table 65. Creative PEGworks Business Overview
Table 66. Creative PEGworks PEGylation Proteins Technology Product
Table 67. Creative PEGworks Revenue in PEGylation Proteins Technology Business (2020-2025) & (US$ Million)
Table 68. Creative PEGworks Recent Development
Table 69. Celares GmbH Company Details
Table 70. Celares GmbH Business Overview
Table 71. Celares GmbH PEGylation Proteins Technology Product
Table 72. Celares GmbH Revenue in PEGylation Proteins Technology Business (2020-2025) & (US$ Million)
Table 73. Celares GmbH Recent Development
Table 74. Creative Diagnostics Company Details
Table 75. Creative Diagnostics Business Overview
Table 76. Creative Diagnostics PEGylation Proteins Technology Product
Table 77. Creative Diagnostics Revenue in PEGylation Proteins Technology Business (2020-2025) & (US$ Million)
Table 78. Creative Diagnostics Recent Development
Table 79. Enzon Pharmaceuticals, Inc. Company Details
Table 80. Enzon Pharmaceuticals, Inc. Business Overview
Table 81. Enzon Pharmaceuticals, Inc. PEGylation Proteins Technology Product
Table 82. Enzon Pharmaceuticals, Inc. Revenue in PEGylation Proteins Technology Business (2020-2025) & (US$ Million)
Table 83. Enzon Pharmaceuticals, Inc. Recent Development
Table 84. Laysan Bio, Inc. Company Details
Table 85. Laysan Bio, Inc. Business Overview
Table 86. Laysan Bio, Inc. PEGylation Proteins Technology Product
Table 87. Laysan Bio, Inc. Revenue in PEGylation Proteins Technology Business (2020-2025) & (US$ Million)
Table 88. Laysan Bio, Inc. Recent Development
Table 89. Merck KGaA Company Details
Table 90. Merck KGaA Business Overview
Table 91. Merck KGaA PEGylation Proteins Technology Product
Table 92. Merck KGaA Revenue in PEGylation Proteins Technology Business (2020-2025) & (US$ Million)
Table 93. Merck KGaA Recent Development
Table 94. NOF America Corp. Company Details
Table 95. NOF America Corp. Business Overview
Table 96. NOF America Corp. PEGylation Proteins Technology Product
Table 97. NOF America Corp. Revenue in PEGylation Proteins Technology Business (2020-2025) & (US$ Million)
Table 98. NOF America Corp. Recent Development
Table 99. Pfizer Company Details
Table 100. Pfizer Business Overview
Table 101. Pfizer PEGylation Proteins Technology Product
Table 102. Pfizer Revenue in PEGylation Proteins Technology Business (2020-2025) & (US$ Million)
Table 103. Pfizer Recent Development
Table 104. Profacgen Company Details
Table 105. Profacgen Business Overview
Table 106. Profacgen PEGylation Proteins Technology Product
Table 107. Profacgen Revenue in PEGylation Proteins Technology Business (2020-2025) & (US$ Million)
Table 108. Profacgen Recent Development
Table 109. Thermo Fisher Scientific, Inc. Company Details
Table 110. Thermo Fisher Scientific, Inc. Business Overview
Table 111. Thermo Fisher Scientific, Inc. PEGylation Proteins Technology Product
Table 112. Thermo Fisher Scientific, Inc. Revenue in PEGylation Proteins Technology Business (2020-2025) & (US$ Million)
Table 113. Thermo Fisher Scientific, Inc. Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
Table 117. Authors List of This Report
List of Figures
Figure 1. PEGylation Proteins Technology Picture
Figure 2. Global PEGylation Proteins Technology Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global PEGylation Proteins Technology Market Share by Type: 2024 VS 2031
Figure 4. Colony-stimulating Factor Features
Figure 5. Interferons Features
Figure 6. Erythropoietin Features
Figure 7. Recombinant Factor VII Features
Figure 8. Others Features
Figure 9. Global PEGylation Proteins Technology Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global PEGylation Proteins Technology Market Share by Application: 2024 VS 2031
Figure 11. Pharmaceutical & Biotechnology Companies Case Studies
Figure 12. Contract Research Organizations (CROs) Case Studies
Figure 13. Academic & Research Institutes Case Studies
Figure 14. PEGylation Proteins Technology Report Years Considered
Figure 15. Global PEGylation Proteins Technology Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global PEGylation Proteins Technology Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global PEGylation Proteins Technology Market Share by Region: 2024 VS 2031
Figure 18. Global PEGylation Proteins Technology Market Share by Players in 2024
Figure 19. Global Top PEGylation Proteins Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PEGylation Proteins Technology as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by PEGylation Proteins Technology Revenue in 2024
Figure 21. North America PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America PEGylation Proteins Technology Market Share by Country (2020-2031)
Figure 23. United States PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe PEGylation Proteins Technology Market Share by Country (2020-2031)
Figure 27. Germany PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific PEGylation Proteins Technology Market Share by Region (2020-2031)
Figure 35. China PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America PEGylation Proteins Technology Market Share by Country (2020-2031)
Figure 43. Mexico PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa PEGylation Proteins Technology Market Share by Country (2020-2031)
Figure 47. Turkey PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE PEGylation Proteins Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Abcam Plc. Revenue Growth Rate in PEGylation Proteins Technology Business (2020-2025)
Figure 51. Aurigene Pharmaceutical Services Ltd. Revenue Growth Rate in PEGylation Proteins Technology Business (2020-2025)
Figure 52. BroadPharm Revenue Growth Rate in PEGylation Proteins Technology Business (2020-2025)
Figure 53. Creative PEGworks Revenue Growth Rate in PEGylation Proteins Technology Business (2020-2025)
Figure 54. Celares GmbH Revenue Growth Rate in PEGylation Proteins Technology Business (2020-2025)
Figure 55. Creative Diagnostics Revenue Growth Rate in PEGylation Proteins Technology Business (2020-2025)
Figure 56. Enzon Pharmaceuticals, Inc. Revenue Growth Rate in PEGylation Proteins Technology Business (2020-2025)
Figure 57. Laysan Bio, Inc. Revenue Growth Rate in PEGylation Proteins Technology Business (2020-2025)
Figure 58. Merck KGaA Revenue Growth Rate in PEGylation Proteins Technology Business (2020-2025)
Figure 59. NOF America Corp. Revenue Growth Rate in PEGylation Proteins Technology Business (2020-2025)
Figure 60. Pfizer Revenue Growth Rate in PEGylation Proteins Technology Business (2020-2025)
Figure 61. Profacgen Revenue Growth Rate in PEGylation Proteins Technology Business (2020-2025)
Figure 62. Thermo Fisher Scientific, Inc. Revenue Growth Rate in PEGylation Proteins Technology Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Advanced Enteric Capsules Market Research Report 2025
Jul 08, 25
Global Outdoor Structures and Chairs Market Research Report 2025
Jul 08, 25
Global Herbs Ingredients Market Research Report 2025
Jul 08, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232